Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: application to a pilot pharmacokinetic study in rats.
about
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I MetabolitesA sensitive liquid chromatography-mass spectrometry bioanalytical assay for a novel anticancer candidate--ZMC1.Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents.Understanding the metabolism of the anticancer drug Triapine: electrochemical oxidation, microsomal incubation and in vivo analysis using LC-HRMS.Comparison of metabolic pathways of different α-N-heterocyclic thiosemicarbazones.
P2860
Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: application to a pilot pharmacokinetic study in rats.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Simultaneous determination of ...... pharmacokinetic study in rats.
@en
type
label
Simultaneous determination of ...... pharmacokinetic study in rats.
@en
prefLabel
Simultaneous determination of ...... pharmacokinetic study in rats.
@en
P2093
P2860
P50
P356
P1476
Simultaneous determination of ...... pharmacokinetic study in rats.
@en
P2093
Ján Stariat
Milan Nobilis
Tomáš Eisner
Tomáš Filipský
Vlasta Suprunová
Vít Šesták
P2860
P304
P356
10.1002/BMC.3080
P50
P577
2013-11-20T00:00:00Z